Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article
Open Access

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial

Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, Benjamin Esterni, Daniel Serin, Pierre Kerbrat, Fabrice Andre, Pascal Finetti, Emmanuelle Charafe-Jauffret, Anne-Laure Martin, Mario Campone, Patrice Viens, Daniel Birnbaum, Frédérique Penault-Llorca and François Bertucci*

Breast Cancer Research 2011, 13:R109 doi:10.1186/bcr3051


See related editorial by Perez-Garcia and Cortes, http://breast-cancer-research.com/content/14/1/104

Accesses  

  • Last 30 days: 134 accesses
  • Last 365 days: 1700 accesses
  • All time: 1700 accesses

Cited by

BioMed Central: 1 citation

Editorial   Free

Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?

José Pérez-García, Javier Cortés Breast Cancer Research 2012, 14:104 (31 January 2012)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations